{"transactions":[{"id":1743701,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:49:03.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":93000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":21.38,"underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001104659-23-117115","document":"tm2330435-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117115/tm2330435-12_4seq1.xml","form_type":"4"}},{"id":1743700,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:49:03.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":18.4,"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-23-117115","document":"tm2330435-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117115/tm2330435-12_4seq1.xml","form_type":"4"}},{"id":1743699,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:49:03.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":14.44,"underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001104659-23-117115","document":"tm2330435-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117115/tm2330435-12_4seq1.xml","form_type":"4"}},{"id":1743698,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2023-11-13T14:49:03.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":51790,"price":19,"value":984010.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Company Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Company Common Stock subject to such RSU. Such payment right will vest and become payable in accordance with vesting schedule (including any vesting acceleration provisions) that applied to the corresponding portion of the applicable RSUs immediately prior to the Effective Time"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117115","document":"tm2330435-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117115/tm2330435-12_4seq1.xml","form_type":"4"}},{"id":1743697,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2023-11-13T14:49:03.000Z","date":"2023-11-08","kind":"other","planned":false,"acquired":false,"shares":28349,"price":19,"value":538631.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 26, 2023, among the Issuer, Alfasigma S.p.A. (\"Alfasigma\"), and Interstellar Acquisition Inc., a wholly owned subsidiary of Alfasigma (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of November 8, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right to receive $19.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117115","document":"tm2330435-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117115/tm2330435-12_4seq1.xml","form_type":"4"}},{"id":1778760,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Common Stock","published_at":"2023-09-18T16:01:14.000Z","date":"2023-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1246,"price":11.57,"value":14416.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":80139,"source":{"system":"sec-edgar","filing":"0001104659-23-101573","document":"tm2326328-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923101573/tm2326328-1_4seq1.xml","form_type":"4"}},{"id":1851857,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Common Stock","published_at":"2023-06-16T16:01:20.000Z","date":"2023-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1246,"price":12.04,"value":15001.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":81385,"source":{"system":"sec-edgar","filing":"0001104659-23-072210","document":"tm2318972-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923072210/tm2318972-1_4seq1.xml","form_type":"4"}},{"id":1949860,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Common Stock","published_at":"2023-03-16T16:07:11.000Z","date":"2023-03-14","kind":"tax_withholding","acquired":false,"shares":1246,"price":15.79,"value":19674.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":82631,"source":{"system":"sec-edgar","filing":"0001104659-23-033307","document":"tm239700-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923033307/tm239700-1_4seq1.xml","form_type":"4"}},{"id":2008055,"issuer":{"id":8695,"kind":"organization","name":"Ocean Biomedical, Inc."},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T20:25:14.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a right to purchase 75,000 shares of the common stock, par value $0.0001 per share (collectively, the \"Option Shares\"), of Ocean Biomedical, Inc. (the \"Issuer\") upon the exercise of a ten-year option granted to the Reporting Person as a non-employee director of the Issuer on February 15, 2023 under the Issuer's 2022 Stock Option and Incentive Plan. This option becomes exercisable in 36 monthly installments beginning on March 15, 2023, with 2,083 Option Shares becoming exercisable on each of the first 35 installments and the remaining 2,095 Option Shares becoming exercisable on the final installment, subject to the Reporting Person remaining in service as a member of the Issuer's board of directors on each installment date. This option is exercisable at an exercise price per Option Share equal to the greater of (i) $10, or (ii) the closing trading price of the Issuer's common stock on February 15, 2023, which was $6.06."}],"balance_after":75000,"derivative":{"exercise_price":10,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-23-005544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223005544/ownership.xml","form_type":"4"}},{"id":2040114,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-01-31T16:03:35.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2023."}],"balance_after":24000,"derivative":{"exercise_price":18.4,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-23-008581","document":"tm234878-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008581/tm234878-1_4seq1.xml","form_type":"4"}},{"id":2040113,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Common Stock","published_at":"2023-01-31T16:03:35.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":14700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2023."}],"balance_after":83877,"source":{"system":"sec-edgar","filing":"0001104659-23-008581","document":"tm234878-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008581/tm234878-1_4seq1.xml","form_type":"4"}},{"id":2072343,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D & CMO"}}],"security":"Common Stock","published_at":"2023-01-03T16:01:26.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":765,"price":12.37,"value":9463.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":69177,"source":{"system":"sec-edgar","filing":"0001104659-23-000327","document":"tm231319d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923000327/tm231319d1_4.xml","form_type":"4"}},{"id":2083501,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2022-12-16T16:01:53.000Z","date":"2022-12-14","kind":"tax_withholding","acquired":false,"shares":1246,"price":14.94,"value":18615.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":69942,"source":{"system":"sec-edgar","filing":"0001104659-22-127799","document":"tm2232817-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922127799/tm2232817-1_4seq1.xml","form_type":"4"}},{"id":2157203,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2022-09-16T16:02:13.000Z","date":"2022-09-14","kind":"tax_withholding","acquired":false,"shares":1246,"price":17.14,"value":21356.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":71188,"source":{"system":"sec-edgar","filing":"0001104659-22-100803","document":"tm2225991-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922100803/tm2225991-1_4seq1.xml","form_type":"4"}},{"id":2229793,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2022-06-16T16:01:23.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":4984,"price":12.1,"value":60306.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":72434,"source":{"system":"sec-edgar","filing":"0001104659-22-071868","document":"tm2218572-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922071868/tm2218572-1_4seq1.xml","form_type":"4"}},{"id":2420989,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-31T16:13:55.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2022."}],"balance_after":17600,"derivative":{"exercise_price":14.44,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001104659-22-009551","document":"tm224882-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009551/tm224882-2_4seq1.xml","form_type":"4"}},{"id":2420988,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2022-01-31T16:13:55.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":10300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2022."}],"balance_after":77418,"source":{"system":"sec-edgar","filing":"0001104659-22-009551","document":"tm224882-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009551/tm224882-2_4seq1.xml","form_type":"4"}},{"id":2668043,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-15T19:01:34.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the options subject to the award will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the remaining options will vest and become exercisable in equal monthly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021."}],"balance_after":93000,"derivative":{"exercise_price":21.38,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001104659-21-081624","document":"tm2119808-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921081624/tm2119808-2_4seq1.xml","form_type":"4"}},{"id":2668042,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and CMO"}}],"security":"Common Stock","published_at":"2021-06-15T19:01:34.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":67118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the shares subject to the award will vest on the first anniversary of the Vesting Commencement Date, and the remaining shares will vest in equal quarterly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021."}],"balance_after":67118,"source":{"system":"sec-edgar","filing":"0001104659-21-081624","document":"tm2119808-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921081624/tm2119808-2_4seq1.xml","form_type":"4"}},{"id":3686902,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-25T16:40:18.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":2.41,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-19-005356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919119005356/doc4.xml","form_type":"4"}},{"id":3894249,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-06-14T11:52:39.000Z","date":"2018-06-12","kind":"purchase","acquired":true,"shares":10000,"price":4.5015,"value":45015.0,"ownership":{"direct":false,"nature":"By the M. Michelle Berrey Revocable Trust u/a 12/30/08"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of purchase prices paid is $4.445 to $4.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":99685,"source":{"system":"sec-edgar","filing":"0001209191-18-037645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118037645/doc4.xml","form_type":"4"}},{"id":3939237,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-10T17:34:23.000Z","date":"2018-05-08","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after November 12, 2012; the remainder of the shares vest in equal monthly installments thereafter over the next three years."}],"balance_after":15161,"derivative":{"exercise_price":4.26,"expiration_date":"2022-11-17","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-18-029338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118029338/doc4.xml","form_type":"4"}},{"id":3939236,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-10T17:34:23.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":11250,"price":4.26,"value":47925.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,670 shares of Common Stock that were acquired by the Reporting Person on March 9, 2018 pursuant to the Issuer's Employee Stock Purchase Plan. Also, includes 25,000 shares of Common Stock issued pursuant to the vesting of restricted stock unit awards on May 9, 2018. Of the 325,256 shares noted above, 80,500 shares are time-based restricted stock unit awards that are unvested."}],"balance_after":325256,"source":{"system":"sec-edgar","filing":"0001209191-18-029338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118029338/doc4.xml","form_type":"4"}},{"id":4006112,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-08T16:53:20.000Z","date":"2018-03-06","kind":"exercise","acquired":false,"shares":10071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after November 12, 2012; the remainder of the shares vest in equal monthly installments thereafter over the next three years."}],"balance_after":26411,"derivative":{"exercise_price":4.26,"expiration_date":"2022-11-17","underlying":"Common Stock","underlying_shares":10071},"source":{"system":"sec-edgar","filing":"0001209191-18-018100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118018100/doc4.xml","form_type":"4"}},{"id":4006111,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-08T16:53:20.000Z","date":"2018-03-06","kind":"exercise","acquired":true,"shares":10071,"price":4.26,"value":42902.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 792 shares of Common Stock that were acquired by the Reporting Person on September 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Of the 311,336 shares noted above, 105,500 shares are time-based restricted stock unit awards that are unvested."}],"balance_after":311336,"source":{"system":"sec-edgar","filing":"0001209191-18-018100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118018100/doc4.xml","form_type":"4"}},{"id":4086725,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-29T15:52:34.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":4.68,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-18-005822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118005822/doc4.xml","form_type":"4"}},{"id":4274693,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T16:21:56.000Z","date":"2017-06-21","kind":"exercise","acquired":false,"shares":23474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after November 12, 2012; the remainder of the shares vest in equal monthly installments thereafter over the next three years."}],"balance_after":36482,"derivative":{"exercise_price":4.26,"expiration_date":"2022-11-17","underlying":"Common Stock","underlying_shares":23474},"source":{"system":"sec-edgar","filing":"0001209191-17-041364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919117041364/doc4.xml","form_type":"4"}},{"id":4274692,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-22T16:21:56.000Z","date":"2017-06-21","kind":"exercise","acquired":true,"shares":23474,"price":4.26,"value":99999.24,"ownership":{"direct":true},"balance_after":323947,"source":{"system":"sec-edgar","filing":"0001209191-17-041364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919117041364/doc4.xml","form_type":"4"}},{"id":4367123,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-31T16:52:24.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":4523,"price":4.097,"value":18530.731,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":366684,"source":{"system":"sec-edgar","filing":"0001209191-17-023886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919117023886/doc4.xml","form_type":"4"}},{"id":4480734,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T17:47:56.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":148000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant."}],"balance_after":148000,"derivative":{"exercise_price":5.14,"expiration_date":"2027-01-23","underlying":"Common Stock","underlying_shares":148000},"source":{"system":"sec-edgar","filing":"0001209191-17-005769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919117005769/doc4.xml","form_type":"4"}},{"id":4480733,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-26T17:47:56.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs shall vest on January 24, 2018, 25% of the RSUs shall vest on January 24, 2019, 25% of the RSUs shall vest on January 24, 2020 and the remaining 25% of the RSUs shall vest on January 24, 2021."}],"balance_after":362161,"source":{"system":"sec-edgar","filing":"0001209191-17-005769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919117005769/doc4.xml","form_type":"4"}},{"id":4537377,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T16:17:16.000Z","date":"2016-11-29","kind":"exercise","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after November 12, 2012; the remainder of the shares vest in equal monthly installments thereafter over the next three years."}],"balance_after":59956,"derivative":{"exercise_price":4.26,"expiration_date":"2022-11-17","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001209191-16-152670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919116152670/doc4.xml","form_type":"4"}},{"id":4537376,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-01T16:17:16.000Z","date":"2016-11-29","kind":"exercise","acquired":true,"shares":2400,"price":4.26,"value":10224.0,"ownership":{"direct":true},"balance_after":288161,"source":{"system":"sec-edgar","filing":"0001209191-16-152670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919116152670/doc4.xml","form_type":"4"}},{"id":4600268,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":108346,"kind":"person","name":"Berrey M Michelle","position":1,"cik":"0001397329","reported_name":"Berrey M Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-19T17:17:04.000Z","date":"2016-09-09","kind":"grant","acquired":true,"shares":4523,"price":4.05,"value":18318.15,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":285761,"source":{"system":"sec-edgar","filing":"0001209191-16-142029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919116142029/doc4.xml","form_type":"4"}}]}